Stock Price
9.49
Daily Change
0.07 0.74%
Monthly
1.82%
Yearly
39.15%
Q1 Forecast
9.00

Grifols reported EUR482.04M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
aTyr Pharma USD -26.58M 26.32M Sep/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
Grifols EUR 482.04M 7.04M Sep/2025